Browse everything: Tickers A–Z · Issuers · Comparisons · Tags
TMED ETF — T. Rowe Price Health Care ETF
T. Rowe Price Health Care ETF (TMED)
Updated October 16, 2026.
Verdict as of October 16, 2026
TMED's distribution is rated unproven by the Dividend Vision Distribution Safety Score™ (50/100, medium confidence). The latest recorded payment is $0.162 (ex-date December 23, 2025).
Sources: T. Rowe Price, Section 19a-1 notices, scoring methodology.
TMED is an ETF. its trailing-12-month yield is 0.49%, its expense ratio is 0.44%. Dividend Vision Distribution Safety Score™ is 50/100 (Unproven). Total return is 223.8% over the past 11.4 years, 115.8 points behind SPY at 339.6%.
T. Rowe Price Health Care ETF is an ETF that invests at least eighty percent of its net assets in healthcare companies, including those engaged in pharmaceutical development, biotechnology, life sciences tools and services, managed healthcare, and healthcare equipment and services. The fund carries a modest expense ratio and currently distributes annually, though the latest distribution was special and may not recur on a regular basis. It appeals to investors seeking equity exposure to the healthcare sector.
TMED dividend yield and income
Price as of 2026-10-16.
Trailing-12-month yield (0.49%) is the last year of cash distributions by ex-date divided by the current price. The dividend amount is $0.162. The ex-dividend date is 12/23/2025. The payment date is 12/26/2025.
| Ex-date | Amount | Change from previous payment |
|---|---|---|
| 2025-12-23 | $0.162 | — |
| 2025 total (partial launch year) | $0.162 | — |
TMED holdings and sector exposure
Holdings are not available for this snapshot.
TMED performance versus SPY
Price and return data through 2026-10-16.
Total return is 223.8% over the past 11.4 years, 115.8 points behind SPY at 339.6%. Over the past year its total return — price change plus distributions reinvested — is 19.8%. Its deepest 1-year drawdown was 11.1%.
| Window | Total return | CAGR |
|---|---|---|
| 1M | -1.7% | — |
| 3M | -3.7% | — |
| 6M | 10.4% | — |
| YTD | 12.1% | — |
| 1Y | 19.8% | — |
| 10Y CAGR | — | 23.30% |
| Since inception (11.4 years) | 223.8% | 10.90% |
TMED key facts
- Distribution Safety Score™
- 50 · Unproven
- Issuer
- T. Rowe Price
- Asset type
- ETF
- Asset class
- Equity
- Inception date
- 06/11/2025
- Expense ratio
- 0.44%
- Distribution frequency
- Annual
- Trailing yield
- 0.49%
- Last close
- $33.33 (as of 2026-10-16)
- AUM
- $32,359,357
- Average volume
- 6220.0
- Dividend
- $0.162
- Ex-dividend date
- 12/23/2025
- Payment date
- 12/26/2025
- Beta
- 0.6984
How Dividend Vision calculates yield and returns
Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield (0.49%) is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.
Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology
Sources and review
Primary sources: T. Rowe Price; prices and distributions from Dividend Vision, derived from vendor EOD data.
Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.
TMED risks and drawbacks
Payments are annual, so cash flow is lumpy versus a monthly fund. Total return has trailed SPY over the available window. The deepest 1-year drawdown on record here is 11.1%.
Who may consider TMED — and who may not
It is a weaker fit for investors who need monthly cash flow (TMED pays annual); investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.
More on TMED
Frequently asked questions
Does TMED pay monthly?
No. TMED currently pays annual, not monthly.
What is TMED's expense ratio?
TMED's expense ratio is 0.44%.
When does TMED pay a dividend?
TMED pays annual. The dividend amount is $0.162. The ex-dividend date is 12/23/2025. The payment date is 12/26/2025.
How has TMED performed?
Total return is 223.8% over the past 11.4 years, 115.8 points behind SPY at 339.6%. Over the past year its total return — price change plus distributions reinvested — is 19.8%. Its deepest 1-year drawdown was 11.1%.
Is TMED a good investment?
TMED's Dividend Vision Distribution Safety Score is 50 (Unproven). That is a risk signal, not investment advice. Compare peers below rather than treating any single figure as a buy or sell.
More securities from T. Rowe Price.
Tickers
Holdings as-of date unavailable.
| Ticker | Name | Weight |
|---|
See how this investment would fit into your portfolio.